We found that the downregulation of IL-17 expression inhibited the PI3K/AKT pathway, which in turn significantly evaluated the activation of the FAS/FASL pathway, leading to enhanced apoptosis of LC cells. The gene discussed is FAS; the disease is laryngotracheoesophageal cleft.